Your browser doesn't support javascript.
loading
Erratum to: JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.
Lee, Yi Fang; Miller, Lance David; Chan, Xiu Bin; Black, Michael A; Pang, Brendan; Ong, Chee Wee; Salto-Tellez, Manuel; Liu, Edison T; Desai, Kartiki V.
Affiliation
  • Lee YF; Clearbridge BioMedics Private Ltd, 81 Science Park Drive, Singapore, Singapore.
  • Miller LD; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA.
  • Chan XB; Clearbridge BioMedics Private Ltd, 81 Science Park Drive, Singapore, Singapore.
  • Black MA; Department of Biochemistry, Otago School of Medical Sciences, University of Otago, 710 Cumberland Street, Dunedin, 9054, New Zealand.
  • Pang B; Department of Pathology, National University Health System and National University of Singapore, 5 Lower Kent Ridge Road, Singapore, 119074, Singapore.
  • Ong CW; Department of Pathology, National University Health System and National University of Singapore, 5 Lower Kent Ridge Road, Singapore, 119074, Singapore.
  • Salto-Tellez M; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • Liu ET; Cancer Science Institute, National University of Singapore, 28 Medical Drive, Singapore, 117456, Singapore.
  • Desai KV; The Jackson Laboratory, Bar Harbor, ME, 04609, USA.
Breast Cancer Res ; 19(1): 42, 2017 03 28.
Article in En | MEDLINE | ID: mdl-28351428
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Breast Cancer Res Journal subject: NEOPLASIAS Year: 2017 Type: Article Affiliation country: Singapore
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Breast Cancer Res Journal subject: NEOPLASIAS Year: 2017 Type: Article Affiliation country: Singapore